Increased YKL-40 expression in patients with carotid atherosclerosis

Abstract Objective We hypothesized a role for the inflammatory protein YKL-40 in atherogenesis and plaque destabilization based on its role in macrophage activation, tissue remodeling, and angiogenesis. Methods Serum YKL-40 levels were measured by enzyme immunoassay in 89 patients with carotid ather...

Full description

Saved in:
Bibliographic Details
Published inAtherosclerosis Vol. 211; no. 2; pp. 589 - 595
Main Authors Michelsen, Annika E, Rathcke, Camilla N, Skjelland, Mona, Holm, Sverre, Ranheim, Trine, Krohg-Sørensen, Kirsten, Klingvall, Marit F, Brosstad, Frank, Øie, Erik, Vestergaard, Henrik, Aukrust, Pål, Halvorsen, Bente
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Ireland Ltd 01.08.2010
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Objective We hypothesized a role for the inflammatory protein YKL-40 in atherogenesis and plaque destabilization based on its role in macrophage activation, tissue remodeling, and angiogenesis. Methods Serum YKL-40 levels were measured by enzyme immunoassay in 89 patients with carotid atherosclerosis and 20 healthy controls. Carotid expression of YKL-40 was examined by real time RT-PCR in 57 of the patients. Regulation and effect of YKL-40 were examined in THP-1 monocytes. Results Our main findings were: (1) serum YKL-40 levels were significantly elevated in patients with carotid atherosclerosis, with particularly high levels in those with symptomatic disease; (2) patients with recent ischemic symptoms (within 2 months) had higher YKL-40 mRNA levels in carotid plaque than other patients; (3) in vitro , the β-adrenergic receptor agonist isoproterenol, toll-like receptor (TLR) 2 and TLR4 agonists, and in particular releasate from activated platelets significantly increased the expression of YKL-40 in THP-1 monocytes and (4) in vitro , YKL-40 increased matrix metalloproteinase-9 expression and activity in THP-1 monocytes, involving activation of p38 mitogen-activated protein kinase. Conclusions Our findings suggest that YKL-40 might be a marker of plaque instability, potentially reflecting macrophage activation and matrix degradation within the atherosclerotic lesion.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0021-9150
1879-1484
DOI:10.1016/j.atherosclerosis.2010.02.035